NANOG and sarcoma: In summary, our work showed that EMX1 and EMX2 act as tumor suppressors by suppressing the activity of stem cell regulatory genes (OCT4, KLF4, MYC, SOX2, NANOG, NES, and PROM1) in sarcoma.